Literature DB >> 2931076

Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies.

S Vora, R Oskam, G E Staal.   

Abstract

In man and the rabbit, 6-phosphofructokinase (PFK, EC 2.7.1.11) exists in tetrameric isoenzymic forms composed of muscle (M or A), liver (L or B) and platelet or brain (P or C) subunits, which are under separate genetic control. In contrast, the genetic control of the rat PFK has not yet been conclusively established; it is unclear whether the P-type or C-type subunit exists in this species. To resolve this question, we investigated the enzyme from the skeletal muscle, liver and brain of rats of Wag/Rij strain. Our studies demonstrate that the rat PFK is also under the control of three structural loci and that the homotetramers M4, P4 and L4 exhibit unique chromatographic, immunological and kinetic-regulatory properties. Skeletal-muscle and brain PFKs consist of isolated M4 and P4 homotetramers respectively. Although liver PFK consists predominantly of L4 homotetramer, it also contains small amounts of PL3 and P2L2 species. All three PFKs exhibit allosteric properties: co-operativity with fructose 6-phosphate and inhibition by ATP decrease in the order P4 greater than L4 greater than M4. P4 and M4 tetramers are the most sensitive to citrate inhibition, whereas L4 tetramer is the least sensitive. More importantly, P4 and L4 isoenzymes are the most sensitive to activation by fructose 2,6-bisphosphate, whereas M4 isoenzyme is the least sensitive. These results indicate that the brain PFK in this strain of rat is a unique tetramer, P4, which also exhibits allosteric kinetics, as do the well-studied M4 and L4 isoenzymes. The reported differences in the number and nature of isoenzymes present in the rat brain and liver most probably reflect the differences in the strains studied by previous investigators. Since the nature of the rat PFK isoenzymes and nomenclatures reported by previous investigators have been now reconciled, it is proposed that, for the sake of uniformity, only well-established nomenclatures used for the rabbit or human PFK isoenzymes be used for the rat isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931076      PMCID: PMC1145065          DOI: 10.1042/bj2290333

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  A COMPARISON OF THE KINETIC PROPERTIES OF PHOSPHOFRUCTOKINASE FROM BACTERIAL, PLANT AND ANIMAL SOURCES.

Authors:  O H LOWRY; J V PASSONNEAU
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-05-11

Review 2.  Phosphofructokinase.

Authors:  K Uyeda
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

3.  Multiple forms of phosphofructokinase in rat tissues and rat tumors.

Authors:  N Kurata; T Matsushima; T Sugimura
Journal:  Biochem Biophys Res Commun       Date:  1972-08-07       Impact factor: 3.575

4.  Rabbit brain phosphofructokinase. Comparison of regulatory properties with those of other phosphofructokinase isozymes.

Authors:  M Y Tsai; R G Kemp
Journal:  J Biol Chem       Date:  1974-10-25       Impact factor: 5.157

5.  Rat liver phosphofructokinase isozymes.

Authors:  G A Dunaway; G Weber
Journal:  Arch Biochem Biophys       Date:  1974-06       Impact factor: 4.013

6.  The distribution of two chromatographically distinguishable forms of phosphofructokinase in the tissues of the rat.

Authors:  C B Taylor; M Bew
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

7.  Studies on multimolecular forms of phosphofructokinase in rat tissues.

Authors:  T Tanaka; T An; Y Sakaue
Journal:  J Biochem       Date:  1971-03       Impact factor: 3.387

8.  Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

Authors:  S Vora; C Seaman; S Durham; S Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  Kinetic properties of human F4 phosphofructokinase: a poor regulatory enzyme.

Authors:  M C Meienhofer; D Cottreau; J C Dreyfus; A Kahn
Journal:  FEBS Lett       Date:  1980-02-11       Impact factor: 4.124

10.  Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system.

Authors:  S Vora
Journal:  Blood       Date:  1981-04       Impact factor: 22.113

View more
  15 in total

1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in rat brain.

Authors:  F Ventura; J L Rosa; S Ambrosio; J Gil; R Bartrons
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

2.  Are the rat tissue/organ proportions of 6-phosphofructo-1-kinase subunits strain-specific?

Authors:  G A Dunaway; T Kasten
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

3.  Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells.

Authors:  Daniel R Crooks; Nunziata Maio; Andrew N Lane; Michal Jarnik; Richard M Higashi; Ronald G Haller; Ye Yang; Teresa W-M Fan; W Marston Linehan; Tracey A Rouault
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

4.  EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.

Authors:  Jong-Ho Lee; Rui Liu; Jing Li; Yugang Wang; Lin Tan; Xin-Jian Li; Xu Qian; Chuanbao Zhang; Yan Xia; Daqian Xu; Wei Guo; Zhiyong Ding; Linyong Du; Yanhua Zheng; Qianming Chen; Philip L Lorenzi; Gordon B Mills; Tao Jiang; Zhimin Lu
Journal:  Mol Cell       Date:  2018-04-19       Impact factor: 17.970

5.  Evolution of allosteric citrate binding sites on 6-phosphofructo-1-kinase.

Authors:  Aleksandra Usenik; Matic Legiša
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

6.  Fructose-2,6-bisphosphate is lower in copper deficient rat cerebellum despite higher content of phosphorylated AMP-activated protein kinase.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Exp Biol Med (Maywood)       Date:  2008-08-14

7.  Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.

Authors:  S Vora; U Giger; S Turchen; J W Harvey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Aripiprazole increases NADPH level in PC12 cells: the role of NADPH oxidase.

Authors:  Hiroshi Nagasaki; Akira Nakashima; Yoko S Kaneko; Yu Kodani; Takeshi Takayanagi; Mitsuyasu Itoh; Kazunao Kondo; Toshiharu Nagatsu; Yoji Hamada; Miyuki Ota; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2013-08-10       Impact factor: 3.575

9.  Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.

Authors:  Andreja Šmerc; Eva Sodja; Matic Legiša
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

10.  Liver X receptor α is involved in the transcriptional regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene.

Authors:  Li-Feng Zhao; Yasumasa Iwasaki; Mitsuru Nishiyama; Takafumi Taguchi; Makoto Tsugita; Mizuho Okazaki; Shuichi Nakayama; Machiko Kambayashi; Shimpei Fujimoto; Koshi Hashimoto; Koji Murao; Yoshio Terada
Journal:  Diabetes       Date:  2012-03-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.